Package-Ref™ HRD Cocktail Reference Standard

Inquiry now
Package-Ref® HRD Cocktail Reference Standard
Cat No.RQP90023
FormatGenomic DNA
BackgroundIn terms of mechanism of action, tumor cells with HRD are more sensitive to platinum drugs or PARP inhibitors. In ovarian cancer, BRCA gene mutation, HRR gene mutation, gene promoter methylation, and other reasons can all cause HRD. HRD testing may provide opportunities for benefit for BRCA-negative patients. HRD positive is a reasonable biomarker for choosing maintenance therapy with PARP inhibitors.








Catalog IDSample匹配度HRD Score药敏HRR备注COA下载
RQP90023-1HRD-P10.86Positive -High78.4500x WES分享配对样本请点击下载
RQP90023-2HRD-P20.84Positive -High33.73500x WES分享配对样本请点击下载
RQP90023-9HRD-P90.9Positive-HighN/A500x WES分享配对样本请点击下载
RQP90023-3HRD-P30.8Positive-High144.54500x WES分享配对样本请点击下载
RQP90023-4HRD-P40.83Critical Value-Median67.9500x WES分享配对样本请点击下载
RQP90023-15HRD-P150.88Critical Value-MedianN/A500x WES分享配对样本请点击下载
RQP90023-10HRD-P100.92Negative-Low100500x WES分享配对样本请点击下载
RQP90023-13HRD-P130.95Negative-Low2.14500x WES分享配对样本请点击下载








Product Information 
Intended UseResearch Use Only
Unit Size1ug/vial * 2 vials
ConcentrationDownload for COA
PurityDownload for COA
DNA ElectrophoresisDownload for COA
Storage4°C
Expiry36 months from the date of manufacture